formoterol fumarate
PolandDrugs containing this active substance
-
It is used to treat symptoms (such as shortness of breath and wheezing) of moderate to severe bronchial asthma. It may also be used to relieve cough and shortness of breath in people with chronic obstructive pulmonary disease (COPD) who require long-term bronchodilator treatment.
Form: solution, inhalation spray
Active substance Dosage formoterol fumarate 0.012 mg ATC: R03AC13
Manufacturer: Chiesi Farmaceutici S.p.A.
-
The medicine is used for the long-term treatment of chronic asthma (moderate to severe) and for the relief of bronchospasm symptoms in patients with chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation in hard capsule
Active substance Dosage formoterol fumarate 12 mcg ATC: R03AC13
Manufacturer: Bausch Health Poland Sp. z o.o. SMB Technology S.A.
-
This medicine is used to treat and prevent asthma symptoms (such as wheezing, shortness of breath, and coughing) and to treat and prevent symptoms of chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage formoterol fumarate 12 mcg ATC: R03AC13
Manufacturer: Orion Corporation
-
The medicinal product is used for the maintenance treatment of airway obstruction symptoms in patients with asthma (in combination with inhaled glucocorticosteroids) and to prevent exercise-induced symptoms. It is also indicated for the treatment of airway obstruction symptoms in individuals with chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage formoterol fumarate 20 mg ATC: R03AC13
Manufacturer: AstraZeneca AB
-
The medicinal product is used for the maintenance treatment of airway obstruction symptoms in patients with asthma (in combination with inhaled steroids) and for the prevention of exercise-induced symptoms. It is also indicated for the treatment of airway obstruction symptoms in patients with chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage formoterol fumarate 10 mg ATC: R03AC13
Manufacturer: AstraZeneca AB
-
The medicine is used for the long-term treatment of moderate to severe bronchial asthma (in combination with anti-inflammatory treatment) and for relieving bronchospasm symptoms in people with chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation in hard capsule
Active substance Dosage formoterol fumarate 12 mcg ATC: R03AC13
Manufacturer: SMB Technology S.A. Pharmaceutical Plants POLPHARMA S.A.
-
The medicine is used to treat asthma in adults, adolescents, and children aged 6 years and older. It helps prevent asthma symptoms by reducing inflammation in the lungs and relaxing the muscles in the airways, which makes breathing easier.
Form: powder for inhalation
Active substance Dosage budesonide 80 mcg formoterol fumarate 4.5 mcg ATC: R03AK07
Manufacturer: AstraZeneca AB
-
The medicine is used for the treatment of asthma in adults and adolescents (from 12 to 17 years old) and for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.
Form: powder for inhalation
Active substance Dosage budesonide 160 mcg formoterol fumarate 4.5 mcg ATC: R03AK07
Manufacturer: AstraZeneca AB
-
This medicine is used to treat asthma in adults and adolescents aged 12 to 17 years, as well as to treat the symptoms of chronic obstructive pulmonary disease (COPD) in adults.
Form: powder for inhalation
Active substance Dosage budesonide 320 mcg formoterol fumarate 9 mcg ATC: R03AK07
Manufacturer: AstraZeneca AB
-
The medicine is used to prevent and treat bronchoconstriction in people with bronchial asthma (as an adjunct to inhaled steroid treatment) and in patients with chronic obstructive pulmonary disease (COPD). It also helps to prevent bronchospasm induced by physical exertion, cold air, or allergens.
Form: powder for inhalation in hard capsules
Active substance Dosage formoterol fumarate 12 mcg ATC: R03AC13
Manufacturer: Adamed Pharma S.A.